MedPath

Comparison between silodosin and tamsulosin for medical expulsive therapy of lower ureteric stones

Phase 3
Conditions
Health Condition 1: N219- Calculus of lower urinary tract, unspecified
Registration Number
CTRI/2020/11/029244
Lead Sponsor
Atif Abdullah C
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients with lower ureteric stone less than 10mm are included

Exclusion Criteria

Bilateral renal or ureteric stone and patient with sepsis are excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Passage of stone within 2 weeksTimepoint: Passage of stone within 2 weeks
Secondary Outcome Measures
NameTimeMethod
Patient not passing stone till 2weeks of therapyTimepoint: 2 weeks
© Copyright 2025. All Rights Reserved by MedPath